2024 Alliance Spring Hybrid Group Meeting Convenes May 15-18

May 9, 2024

Meeting book

Congratulations to the VCU Massey Cancer Center Minority Underserved NCORP for the 2024 Alliance Spring Hybrid Group Meeting Book cover design. As an awardee of a MU-NCORP (formerly referred to as Minority Community Clinical Oncology Program) for more than 30 years, Massey plays a significant role in facilitating the dev

Alliance and Natera Announce Activation of Alliance A032103 (MODERN): A Randomized, Phase II/III Adjuvant Trial in Urothelial Cancer

May 1, 2024

First of its kind study in muscle-invasive urothelial cancer, with both escalation and de-escalation arms
Approximately 1,000 patients will be enrolled at more than 300 sites

The Alliance for Clinical Trials in Oncology and Natera, Inc., a global leader in cell-free DNA testing, recently announced the launch of Alliance A032103 (MO

New Trial Alert: Alliance A062102 Multiple Myeloma

April 4, 2024

Alliance A062102: Randomized phase 2 study of iberdomide maintenance therapy following idecaptagene vicleucel CAR-T in multiple myeloma patients

Overview: Alliance investigator Sascha Tuchman, MD, of UNC Lineberger Comprehensive Cancer Center, leads this phase II trial that compares iberdomide maintenance therapy to disease monitoring for improving survival in patients who have received idecabtagene vicleuc

Older News